breast cancer, sentinel lymph node biopsy, axillary lymph node dissection, luminal, CDK4/6 inhibitor
Triple-negative breast cancer, HER2-low, Genomic profiling, Transcriptomic profiling, Prognosis
triple negative breast cancer, homologous recombination deficiency, clinicopathological factors, pathological response, prognosis